ライフサイエンスコーパス: interassay

1 idation included determination of intra- and interassay accuracy and precision values, recovery studi

2 oncentration range of 0.2-200 ng/mL, and the interassay accuracy, intraassay precision, and interassa

3 In conclusion, GA and LA showed good interassay agreement for the detection of most HPV genot

4 ble to detect more genotypes per sample, the interassay agreement was acceptable (kappa = 0.53, 63% a

5 The overall interassay agreement, type-specific, and single and mult

6 There was substantial interassay agreements for the detection of all HPV genot

7 pecificity, but lack of standardization, and interassay and interlaboratory variation makes it diffic

8 roposed clinical thresholds show significant interassay and intrapatient variability.

9 5% coefficient of variation for intra-assay, interassay, and interoperator variability.

10 The cRMP is highly precise with intra-assay, interassay, and total percent CVs of 2.7%, 1.3%, and 2.4

11 mpetitive enzyme-linked immunosorbent assay (interassay coefficient of variation < or = 10%) and comp

12 is also simple to use, has a relatively low interassay coefficient of variation (<6%), retains its p

13 ad a <10% interassay relative error and <15% interassay coefficient of variation across a range from

14 y is 200 pmol of MetSO per analysis, and the interassay coefficient of variation is 5.8%.

15 The intra-assay and interassay coefficient of variation values for the Lyra

16 CEDIA intra- and interassay coefficients of variation are less than 10%.

17 approximately 0.1 ng Cd/ml, mean intra- and interassay coefficients of variation were 11-12%.

18 The intraassay and interassay coefficients of variation were 29 and 40%.

19 nce of these assays and to permit more-valid interassay comparison.

20 ize BKV NAAT results, we anticipate improved interassay comparisons with a potential for establishing

21 ellent agreement between the assays, with an interassay concordance of 91.35% (kappa = 0.75; 95% conf

22 y, intra-assay CV = 7.7% and ICC = 98.2% and interassay CV = 12.3% and ICC = 94.2%).

23 ficient of variation (CV) was 3.1% while the interassay CV was 15%.

24 this assay was between 0.6 and 3.8%, and the interassay CV was between 1.7 and 3.2%.

25 The sensor had excellent precision (1.9-8.2% interassay CV) and was comparable in performance to comm

26 rformance to single-analyte ELISAs (1.9-8.1% interassay CV; <2 ng/mL (or units/mL) detection limit fo

27 and reproducibility (serum assay, intra- and interassay CVs < 3% and ICCs > 99%; urine assay, intra-a

28 fficients of variation [CVs], 0.8%, and mean interassay CVs, 1.6%) and rapid (3.5 min per assay) and

29 %; SP142 CV, 12.17%-109.61%) and significant interassay discordance using QIF (26.6%).

30 Interassay harmonization of cytomegalovirus (CMV) DNA me

31 Accuracy was >or=85.7% with intra-assay and interassay imprecision<or=13.9 and 12.4%, respectively.

32 Interassay mean accuracies were between 101.5 and 104.7%

33 The intra- and interassay precision (%CV) was within 10.0% and 8.1%, re

34 Interassay precision (mean %RSD) ranged from 4.28 to 17.

35 Interassay precision (n = 6) was 7%.

36 terassay accuracy, intraassay precision, and interassay precision do not exceed 8.6%, 12%, and 12%, r

37 is more than three orders of magnitude, with interassay precision less than 15%.

38 n of < or =2.5% coefficient of variation and interassay precision of < or =4.0% coefficient of variat

39 The accuracy and interassay precision of this LC-MS-MS assay for lycopene

40 The coefficients of variation for intra- and interassay precision were less than 9 and 14%, respectiv

41 lidation results were as follows: intra- and interassay precision with %CV of 8.2-9.9 and 7.1-9.8%, r

42 specimen dilution, good clinical intra- and interassay precision, and excellent correlation with the

43 cimens for linearity, intra-assay precision, interassay precision, limit of detection, and specificit

44 were 3.6-10.9 and 4.81-10.21% for intra- and interassay precision, respectively.

45 h acceptable variability for both intra- and interassay precision.

46 The assay had a <10% interassay relative error and <15% interassay coefficien

47 s per reaction mixture, (vi) high intra- and interassay reproducibilities, and (vii) correct identifi

48 17.2%, and in buffer down to 5.88 fM with an interassay reproducibility (% RSD, n = 3) of 8.4%.

49 se at concentrations down to 58.8 fM with an interassay reproducibility (%RSD of n = 3) < 17.2%, and

50 orphometric techniques had good to excellent interassay reproducibility (R(2) = 0.62 to 0.96) and int

51 We evaluated the intra-assay and interassay reproducibility at low index levels using thr

52 Intraassay and interassay reproducibility of PCR and GM was excellent.

53 ty was found to be between 2.5 and 12.3% and interassay reproducibility was between 6.1 and 15.2% for

54 variability persists, preventing meaningful interassay result comparison.

55 es are quantitative for all nucleotides, and interassay variabilities are between 5 and 7% when quant

56 The mean interassay variabilities were 9.1 and 8.2% for total DPD

57 The estimated standard deviations including interassay variability and intra-assay variability of th

58 Intraassay and interassay variability averaged 6.7% and 8.9%, respectiv

59 ys are especially subject to high intra- and interassay variability because they are not subject to m

60 btained by chemical synthesis, an intra- and interassay variability below 8% and an accuracy of 92% t

61 cients (ICCs) between antibodies to quantify interassay variability for PD-L1 expression in tumor cel

62 Significant interassay variability in the quantification of BK virus

63 ntly improved amplification specificity, and interassay variability is comparable to that of commerci

64 ls heterogeneity within tumors and prominent interassay variability or discordance.

65 Interassay variability was low, and the dynamic range wa

66 peatability (RSDr = 6% and 9% for intra- and interassay variability, respectively) and specificity: o

67 tform is reproducible with minimal intra- or interassay variability.

68 NucliSens generally showed less interassay variability.

69 f the MAIPA protocol with similar intra- and interassay variance.

70 ultured cells and biological samples with an interassay variation of less than 5%.

71 Intra- and interassay variation was less than 10% for a variety of

72 s very accurate and precise, with intra- and interassay variations of less than 3% when 5 microg of p

73 carboxylate (GS4071) to determine intra- and interassay variations.